Amgen Deploys Veeva Vault CRM Globally
News related to:Veeva Systems · 2 min read
Veeva Systems, a leading provider of cloud solutions for the life sciences industry, has announced a significant expansion of its global client base. Amgen, a major biotechnology company, has chosen to deploy Veeva Vault CRM across its operations, marking a new chapter in their long-standing collaboration.
Scott Skellenger, senior vice president and chief information officer at Amgen, highlighted the strategic importance of this move.
Matt Farrell, president of commercial strategy at Veeva, echoed Skellenger's sentiments.
Vault CRM is part of the broader Vault CRM Suite, which serves as the technology foundation for agentic commercial engagement. This suite includes the Agentic Call Report, a tool designed to generate Commercial Evidence and uncover previously hidden treatment barriers. By leveraging these advanced capabilities, Amgen aims to enhance its commercial operations and improve patient outcomes.
Veeva Systems, founded in 2003 and headquartered in Pleasanton, California, has established itself as a key player in the life sciences technology sector. The company's commitment to innovation and product excellence has enabled it to serve over 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is dedicated to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.
Amgen, known for its commitment to improving the health of people around the world, has been a valued client of Veeva for over a decade. This latest agreement underscores the strength of their partnership and Amgen's dedication to leveraging cutting-edge technology to drive innovation in the biotechnology sector.
The deployment of Veeva Vault CRM is expected to streamline Amgen's commercial processes, enabling the company to more efficiently develop and deliver new therapies to patients. This move is part of a broader strategy to enhance patient care and accelerate the development of innovative treatments.
In conclusion, the expansion of Veeva Vault CRM to Amgen marks a significant milestone in the collaboration between the two companies. As Amgen continues to innovate and bring new therapies to market, Veeva's technology will play a crucial role in supporting their mission to improve patient outcomes globally.